Genocea Biosciences Inc (GNCA) Stock: What Does the Chart Say Thursday?

Thursday, May 26, 2022 01:34 PM | InvestorsObserver Analysts

Mentioned in this article

Genocea Biosciences Inc (GNCA) Stock: What Does the Chart Say Thursday?

Overall market sentiment has been down on Genocea Biosciences Inc (GNCA) stock lately. GNCA receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Genocea Biosciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on GNCA!

See Full GNCA Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With GNCA Stock Today?

Genocea Biosciences Inc (GNCA) stock is lower by -14.24% while the S&P 500 is higher by 2.14% as of 1:32 PM on Thursday, May 26. GNCA is lower by -$0.01 from the previous closing price of $0.09 on volume of 26,511,116 shares. Over the past year the S&P 500 is down -2.97% while GNCA is lower by -96.26%. GNCA lost -$0.53 per share in the over the last 12 months.

More About Genocea Biosciences Inc

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns a pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines. Click Here to get the full Stock Report for Genocea Biosciences Inc stock.